<DOC>
	<DOCNO>NCT01604239</DOCNO>
	<brief_summary>This study investigate Shinbaro capsule lower incident gastrointestinal event celecoxib subject osteoarthritis .</brief_summary>
	<brief_title>To Evaluate Safety 'Shinbaro Capsule'in Patients With Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Minimum 19 year old Kellgren stage I ~ III ACR criterion Stable osteoarthritis 3 month Be able perform WOMAC KKS Written consent form voluntarily Disease orthopaedic surgical could affect evaluate efficacy Medication continuous corticosteroid oral articular cavity within 12 week Medication constantly ( 1 week ) antipsychotic drug narcotic analgesic within four week Medical history hypersensitivity reaction Herbal drug Genetic factor galactose intolerance , lapplactase deficiency glucosegalactose malabsorption , etc . Occurrence OA cause injury Diagnosed psychical disorder , take medication Diagnosed active peptic ulcer , gastrointestinal bleeding , inflammatory bowel disease , severe liver dysfunction , severe renal dysfunction , congestive heart failure , clinically significant ischemic heart disease , peripheral arterial disease , cerebrovascular disease Diagnosed esophagus gastrointestinal ulceration within 1 year , treat Abnormal bleeding ( abnormal platelet blood coagulation factor , etc . ) Positive fecal occult blood test Gastrointestinal tract surgery except appendectomy Serum creatinine , ALT , AST , total bilirubin UNL x 1.5 screen test Participation another clinical trial within 4 week Not consent use effectual contraception method trial Pregnant lactate woman Medical history malignant tumor within 5 year Investigator 's judgment</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Shinbaro</keyword>
	<keyword>Herbal drug</keyword>
</DOC>